Objectives

  1. Understand the prevalence of subclinical rejection in kidney transplant recipients
  2. Understand the clinical consequences of subclinical rejection
  3. Become familiar with the indications and performance characteristics of available molecular biomarkers
Session date: 
Thursday, April 9, 2020 - 1:00pm to 2:00pm
Speaker Name: 
John J. Friedewald, MD
Location: 
Via Zoom
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.